Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine

Biochemical and Biophysical Research Communications

Volumn 325, Issue 2, 2004, Pages 500-505

  Yoshikawa, Tomoaki ^a,b   Imazu, Susumu ^a   Gao, Jian Qing ^a   Hayashi, Kazuyuki ^a   Tsuda, Yasuhiro ^a   Shimokawa, Mariko ^b   Sugita, Toshiki ^a,b   Niwa, Takako ^a,b   Oda, Atushi ^a,b   Akashi, Mitsuru ^a,b   Tsutsumi, Yasuo ^b,c   Mayumi, Tadanori ^d   Nakagawa, Shinsaku ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

DNA vaccine; Drug delivery system; Liposome; Tumor vaccine

Indexed keywords

DNA FUSOGENIC LIPOSOME VACCINE; DNA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; GENE TARGETING; GENETICS; IMMUNE RESPONSE; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; TUMOR;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CELL LINE, TUMOR; DNA; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; LIPOSOMES; MALE; MEMBRANE FUSION; MICE; MICE, INBRED C57BL; OVALBUMIN; PHOSPHATIDYLETHANOLAMINES; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 7644227332     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.10.056     Document Type: Article

References (31)

1. J.W. Shiver, M.E. Davies, H.C. Perry, D.C. Freed, and M.A. Liu J. Pharm. Sci. 85 1996 1317 1324
2. R.G. Webster, E.F. Fynan, J.C. Santoro, and H. Robinson Vaccine 12 1994 1495 1498
3. J.J. Donnelly, A. Friedman, D. Martinez, D.L. Montgomery, J.W. Shiver, S.L. Motzel, J.B. Ulmer, and M.A. Liu Nat. Med. 1 1995 583 587
4. E.F. Fynan, R.G. Webster, D.H. Fuller, J.R. Haynes, J.C. Santoro, and H.L. Robinson Proc. Natl. Acad. Sci. USA 90 1993 11478 11482
5. R. Wang Science 282 1998 476 480
6. L. Zhang, G. Widera, S. Bleecher, D.A. Zaharoff, B. Mossop, and D. Rabussay DNA Cell Biol. 22 2003 815 822
7. A.D. Cohen, J.D. Boyer, and D.B. Weiner FASEB J. 12 1998 1611 1626
8. J.Y. Scheerlinck Vaccine 19 2001 2647 2656
9. K. Kawabata, Y. Takakura, and M. Hashida Pharm. Res. 12 1995 825 830
10. S.E. Parker Hum. Gene. Ther. 6 1995 575 590
11. D. Lew Hum. Gene. Ther. 6 1995 553 564
12. J.S. Boyle, A. Silva, J.L. Brady, and A.M. Lew Proc. Natl. Acad. Sci. USA 94 1997 14626 14631
13. Y. Kang, P.A. Calvo, T.M. Daly, and C.A. Long J. Immunol. 161 1998 4211 4219
14. Z. Cui, and R.J. Mumper Eur. J. Pharm. Biopharm. 55 2003 11 18
15. G. Gregoriadis, R. Saffie, and J.B. de Souza FEBS Lett. 402 1997 107 110
16. C.P. Locher, D. Putnam, R. Langer, S.A. Witt, B.M. Ashlock, and J.A. Levy Immunol. Lett. 90 2003 67 70
17. R.J. Mumper, and Z. Cui Methods 31 2003 255 262
18. Z. Cui, C.H. Hsu, and R.J. Mumper Drug Dev. Ind. Pharm. 29 2003 689 700
19. Z. Cui, L. Baizer, and R.J. Mumper J. Biotechnol. 102 2003 105 115
20. Z. Cui, and R.J. Mumper J. Pharm. Pharmacol. 54 2002 1195 1203
21. H. Mizuguchi, T. Nakagawa, M. Nakanishi, S. Imazu, S. Nakagawa, and T. Mayumi Biochem. Biophys. Res. Commun. 218 1996 402 407
22. H. Mizuguchi, T. Nakanishi, M. Nakanishi, T. Nakagawa, S. Nakagawa, and T. Mayumi Cancer Lett. 100 1996 63 69
23. H. Mizuguchi, M. Nakanishi, T. Nakanishi, T. Nakagawa, S. Nakagawa, and T. Mayumi Br. J. Cancer 73 1996 472 476
24. H. Mizuguchi Cancer Res. 58 1998 5725 5730
25. J. Kunisawa, and T. Mayumi Gan To Kagaku Ryoho 28 2001 577 583
26. T. Nakanishi Eur. J. Immunol. 30 2000 1740 1747
27. J. Kunisawa J. Immunol. 167 2001 1406 1412
28. R.T. Hinegardner Anal. Biochem. 39 1971 197 201
29. T. Nakanishi J. Control Release 61 1999 233 240
30. T. Nakanishi Biochem. Biophys. Res. Commun. 240 1997 793 797
31. A. Hayashi Biochem. Biophys. Res. Commun. 261 1999 824 828